About the Company
We do not have any company description for Crinetics Pharmaceuticals, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $CRNX News
Crinetics Pharmaceuticals Inc CRNX
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Crinetics Pharmaceuticals Inc CFO Marc Wilson Sells 6,942 Shares
Marc Wilson, Chief Financial Officer of Crinetics Pharmaceuticals Inc (NASDAQ:CRNX), has sold 6,942 shares of the company on March 19, 2024, according to a recent SEC Filing. The transaction was ...
Crinetics Pharmaceuticals Stock (NASDAQ:CRNX), Analyst Ratings, Price Targets, Predictions
$44.10-4.76% HC Wainwright & Co.
Where Do Analysts Think The Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) Is Going
Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) price closed lower on Friday, April 12, dropping -7.16% below its previous close.
Crinetics Pharmaceuticals Announces April 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, April 11, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on April 10, 2024, the Compensation Committee of Crinetics’ Board of Directors granted ...
Crinetics Pharmaceuticals Inc.
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Crinetics Pharmaceuticals, Inc.: Crinetics Pharmaceuticals Announces April 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, April 11, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on April 10, 2024, the Compensation Committee of Crinetics' Board of Directors granted ...
Crinetics Pharmaceuticals Inc CRNX
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Crinetics Pharmaceuticals, Inc. (CRNX)
Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...
Crinetics Pharmaceuticals Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Crinetics Pharmaceuticals Inc (CRNX)
On Wednesday, JPMorgan updated its outlook on Crinetics Pharmaceuticals (NASDAQ:CRNX), raising the price target on the company's shares to $47 from $35, while maintaining an ...
Loading the latest forecasts...